Hypoxia

In this video from the Annual Meeting of the American Neurological Association, Jennifer Frontera, MD, discussed a plenary session, "Hypoxic/Anoxic Injury in the CNS."

Because sudden cardiac death can occur in patients with CVD traveling to higher altitudes, experts recommended in a new American Heart Association scientific statement that patients with CVD consult a physician before travel.

On February 12, the FDA accepted its first new drug application for a hypoxia-inducible factor prolyl hydroxylase inhibitor. The agency has set a Prescription Drug User Fee Act date of Dec. 20, 2020 for final review and approval.